MOLECULAR GENETICS AND METABOLISM

metrics 2024

Exploring the Nexus of Genetics and Metabolic Science

Introduction

MOLECULAR GENETICS AND METABOLISM, published by Academic Press Inc Elsevier Science, is a distinguished journal that has been at the forefront of advancing research since its inception in 1998. This journal, boasting both ISSN 1096-7192 and E-ISSN 1096-7206, focuses on the intricate interplay between molecular genetics and metabolic processes, making it an invaluable resource for researchers in the fields of biochemistry, endocrinology, and genetics. Recognized for its impact, it ranks in the Q1 and Q2 quartiles across multiple categories in the latest rankings, enhancing its reputation amongst scholars and professionals. With a commitment to disseminating cutting-edge research, it encourages innovative studies and comprehensive reviews that contribute to our understanding of gene function and metabolism. Open access options provide unrestricted access to its significant findings, further solidifying its role as a leading platform for scientific discourse. As it continues to thrive in the academic community, MOLECULAR GENETICS AND METABOLISM serves as a catalyst for novel insights and advancements in molecular biology.

Metrics 2024

SCIMAGO Journal Rank1.09
Journal Impact Factor3.70
Journal Impact Factor (5 years)3.90
H-Index123
Journal IF Without Self3.70
Eigen Factor0.01
Normal Eigen Factor1.36
Influence1.22
Immediacy Index0.90
Cited Half Life9.20
Citing Half Life8.00
JCI0.81
Total Documents4152
WOS Total Citations8206
SCIMAGO Total Citations38898
SCIMAGO SELF Citations3251
Scopus Journal Rank1.09
Cites / Document (2 Years)2.88
Cites / Document (3 Years)3.12
Cites / Document (4 Years)3.34

Metrics History

Rank 2024

Scopus

Endocrinology, Diabetes and Metabolism in Medicine
Rank #89/244
Percentile 63.52
Quartile Q2
Genetics in Biochemistry, Genetics and Molecular Biology
Rank #136/347
Percentile 60.81
Quartile Q2
Endocrinology in Biochemistry, Genetics and Molecular Biology
Rank #58/128
Percentile 54.69
Quartile Q2
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #202/438
Percentile 53.88
Quartile Q2
Molecular Biology in Biochemistry, Genetics and Molecular Biology
Rank #215/410
Percentile 47.56
Quartile Q3

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 62/186
Percentile 66.90
Quartile Q2
GENETICS & HEREDITY
Rank 52/191
Percentile 73.00
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 69/189
Percentile 63.80
Quartile Q2

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 71/186
Percentile 61.83
Quartile Q2
GENETICS & HEREDITY
Rank 70/191
Percentile 63.35
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 68/189
Percentile 64.02
Quartile Q2

Quartile History

Similar Journals

Cold Spring Harbor Perspectives in Medicine

Advancing the Frontiers of Medical Science
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2157-1422Frequency: 12 issues/year

Cold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.

GENETICS AND MOLECULAR BIOLOGY

Empowering researchers to shape the future of biology.
Publisher: SOC BRASIL GENETICAISSN: 1415-4757Frequency: 4 issues/year

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.

HORMONE AND METABOLIC RESEARCH

Pioneering Research for Health and Disease Insights
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

BIOCHEMICAL GENETICS

Exploring the Intersections of Science and Discovery
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0006-2928Frequency: 6 issues/year

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

YEAST

Unveiling the potential of yeast in biotechnology and beyond.
Publisher: WILEYISSN: 0749-503XFrequency: 12 issues/year

YEAST is a renowned peer-reviewed journal published by WILEY, dedicated to advancing the understanding of yeast biology and its applications in various scientific fields. Since its inception in 1985, YEAST has significantly contributed to the disciplines of microbiology, biotechnology, biochemistry, and genetics, achieving respectable rankings within its categories, including Q2 status in Applied Microbiology and Biotechnology and Q2 in Biotechnology as of 2023. With an emphasis on high-quality research, it explores diverse aspects of yeast organisms, from their cellular mechanisms to biotechnological applications. Although it does not currently offer an open-access option, the journal provides valuable insights and findings that are applicable to both academia and industry, making it an essential resource for researchers, professionals, and students interested in the functional and applied dimensions of yeast. With its editorial rigor and commitment to quality, YEAST continues to be a vital platform for disseminating innovative research that shapes future biotechnological advancements.

Annals of Pediatric Endocrinology & Metabolism

Fostering collaboration for innovative pediatric care solutions.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

METABOLIC BRAIN DISEASE

Illuminating pathways to better neurological outcomes.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0885-7490Frequency: 6 issues/year

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

ACTA BIOCHIMICA POLONICA

Connecting Discoveries in Genetics and Molecular Biology
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

ENDOCRINE RESEARCH

Exploring innovative insights in hormonal research.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

CLINICAL ENDOCRINOLOGY

Innovating diagnostics and treatments for endocrine disorders.
Publisher: WILEYISSN: 0300-0664Frequency: 12 issues/year

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.